Search / Trial NCT00000470

Infant Heart Surgery: Central Nervous System Sequelae of Circulatory Arrest

Launched by BOSTON CHILDREN'S HOSPITAL · Oct 27, 1999

Apply for Trial

Trial Information

Current as of September 11, 2024

Completed

Keywords

Description

BACKGROUND: The pediatric medical community has long been concerned about the increased incidence of cerebral dysfunction among newborns with severe cyanotic congenital heart disease. There has been concern about a great number of potential predisposing factors including the effects of hypoxemia and acidosis, trauma during cardiac catheterization, and the duration of prolonged decreased arterial oxygen saturation. Many infants undoubtedly undergo significant brain damage prior to surgery, but may be subject to further insult in the peri-operative period. The proposed trial studied circulat...

Gender

ALL

Eligibility criteria

  • Boy and girl infants, up to three months of age, with transposition of the great arteries with or without septal defect.

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0